Skip to main content
. 2020 Feb 8;8(2):28. doi: 10.3390/biomedicines8020028
ALIOS American Lifestyle Induced Obesity Syndrome
ALMS1 Alström
ALR Augmenter of liver regeneration
APOE2ki Apolipoprotein E2 knock-in
CCl4 Carbon tetrachloride
CD Diet deficient for/low in choline
CDAA Choline-deficient L-amino acid-defined diet
DIAMOND Diet-induced animal model of non-alcoholic fatty liver disease
FLS Fatty liver Shionogi
FXR Farnesoid X receptor
Gank Gankyrin
GFER Growth Factor ERV1 homolog of Saccharomyces cerevisiae
HCC Hepatocellular carcinoma
HFC High-fat/high-cholesterol diet
HFD High-fat diet
Ldlr Low-density lipoprotein receptor
MAT1a methionine adenosyltransferase 1A
MC4R Melanocortin 4 receptor
MetS Metabolic Syndrome
MS-NASH Mice formerly known as FATZO/Pco
NAFLD Non-alcoholic fatty liver disease
NASH Non-alcoholic steatohepatitis
NEMO NF-κB essential modulator
PNPLA3 Patatin-like phospholipase domain-containing 3
PPAR Peroxisome proliferator-activated receptor
PTEN Phosphatase and tensin homolog
T2D Type 2 Diabetes
TAA Thioacetamide
TM6SF2 Transmembrane 6 superfamily member 2
TNFα Tumor necrosis factor α
TSOD Tsumura-Suzuki Obese Diabetes